National Cancer Institute; Notice of Charter Renewal, 38197 [2016-13829]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892, 301–435–
0198, shawdeni@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Biomarkers, Bioassays, Animal
Models and Related Technologies for
Neurologic Disorders.
Date: July 13, 2016.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Yvonne Bennett, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5199,
MSC 7846, Bethesda, MD 20892, 301–379–
3793, bennetty@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 7, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–13827 Filed 6–10–16; 8:45 am]
additional two-year period on April 14,
2016.
It is determined that the National
Cancer Institute Clinical Trials and
Translational Research Advisory
Committee is in the public interest in
connection with the performance of
duties imposed on the National Cancer
Institute and National Institutes of
Health by law, and that these duties can
best be performed through the advice
and counsel of this group.
Inquiries may be directed to Jennifer
Spaeth, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or spaethj@od.nih.gov.
Dated: June 7, 2016.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–13829 Filed 6–10–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
BILLING CODE 4140–01–P
Coast Guard
[Docket No. USCG–2016–0372]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Certificates of Alternative Compliance,
First Coast Guard District
National Institutes of Health
Coast Guard, DHS.
Notice.
AGENCY:
National Cancer Institute; Notice of
Charter Renewal
ACTION:
The Coast Guard announces
that the First Coast Guard District’s
Prevention Department has issued
certificates of alternative compliance
with the International Regulations for
Preventing Collisions at Sea (72
COLREGS), to vessels of special
construction or purpose that cannot
SUMMARY:
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the Charter for the National
Cancer Institute Clinical Trials and
Translational Research Advisory
Committee was renewed for an
38197
fully comply with the light, shape, and
sound signal provisions of 72 COLREGS
without interfering with their special
function. This notice promotes the Coast
Guard’s maritime safety and
stewardship missions.
FOR FURTHER INFORMATION CONTACT: For
information about this document call or
email Mr. Kevin Miller, First Coast
Guard District’s Towing Vessel and
Barge Safety Specialist at (617) 223–
8272 or [Kevin.L.Miller2@uscg.mil].
SUPPLEMENTARY INFORMATION:
Discussion
The United States is signatory to the
International Maritime Organization’s
International Regulations for Preventing
Collisions at Sea, 1972, as amended.
The special construction or purpose of
some vessels makes them unable to
comply with the light, shape, and sound
signal provisions of 72 COLREGS.
Under statutory law 1 and Coast Guard
regulation,2 a vessel may instead meet
alternative requirements and the
vessel’s owner, builder, operator, or
agent may apply for a certificate of
alternative compliance (COAC). The
Chief of the Inspections and
Investigations Branch in each Coast
Guard District office determines
whether the vessel for which the COAC
is sought complies as closely as possible
with 72 COLREGS, and decides whether
to issue the COAC. Once issued, a
COAC remains valid until information
supplied in the application for the
COAC, or the terms of the COAC,
become inapplicable to the vessel.
Under the governing statute 3 and
regulation,4 the Coast Guard must
publish notice of each COAC issued by
the District office.
The First Coast Guard District issued
COACs to the following vessels from
January 2016 to May 2016:
Vessel name
Details
2016 ........................
JACK T MORAN ....................................
2016 ........................
GRACIE M REINAUER .........................
2016 ........................
srobinson on DSK5SPTVN1PROD with NOTICES
Year
COOPER MORAN .................................
This certificate authorized the placement of the vessel’s sidelights in a position
13′ 5.25″ from the vessel’s side, mounted to the top of the pilot house. Additionally, this certificate authorized the placement of the vessel’s stern light
and towing lights in a position 3′ 5.75″ aft of Frame 20, mounted on the top
of the pilot house.
This certificate authorized the placement of the vessel’s sidelights in a position
7′ 1.75″ from the vessel’s side, mounted to the deckhouse overhead.
This certificate authorized the placement of the vessel’s sidelights in a position
13′ 5.25″ from the vessel’s side, mounted to the top of the pilot house. Additionally, this certificate authorized the placement of the vessel’s stern light
and towing lights in a position 3′ 5.75″ aft of Frame 20, mounted on the top
of the pilot house.
1 33
2 33
U.S.C. 1605.
CFR 81.3.
VerDate Sep<11>2014
20:48 Jun 10, 2016
3 33
4 33
Jkt 238001
PO 00000
U.S.C. 1605(c).
CFR 81.18.
Frm 00071
Fmt 4703
Sfmt 4703
E:\FR\FM\13JNN1.SGM
13JNN1
]]>Agencies
[Federal Register Volume 81, Number 113 (Monday, June 13, 2016)]
[Notices]
[Page 38197]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13829]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Charter Renewal
In accordance with Title 41 of the U.S. Code of Federal
Regulations, Section 102-3.65(a), notice is hereby given that the
Charter for the National Cancer Institute Clinical Trials and
Translational Research Advisory Committee was renewed for an additional
two-year period on April 14, 2016.
It is determined that the National Cancer Institute Clinical Trials
and Translational Research Advisory Committee is in the public interest
in connection with the performance of duties imposed on the National
Cancer Institute and National Institutes of Health by law, and that
these duties can best be performed through the advice and counsel of
this group.
Inquiries may be directed to Jennifer Spaeth, Director, Office of
Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or
spaethj@od.nih.gov.
Dated: June 7, 2016.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-13829 Filed 6-10-16; 8:45 am]
BILLING CODE 4140-01-P
